← Leaderboards
Richard E Chaisson
Johns Hopkins University
$50,014,616
Attributed
$50,014,616
Total exposure
24
Grants
19
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $10.4M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$121,886,177 · 26
FDA$517,445 · 1
By mechanism
P30$89,091,495 · 12
R01$17,808,036 · 6
U19$7,419,749 · 2
U01$4,408,909 · 1
U2R$1,633,636 · 1
K24$1,290,186 · 1
Top collaborators
- Petros C Karakousis5 shared
- Denis Godwin Antoine1 shared
- Nathan Alex Irvin1 shared
- Risha Irvin1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Roger H Reeves$24,667,280
- Jonathan E Golub$18,054,199
- Eric L Nuermberger$20,859,483
- Petros C Karakousis$19,415,784
- Gail L Daumit$28,900,560
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelFundingAcquired Immunodeficiency SyndromeResourcesProgramsBaltimoreCommunitiesCollaborationsTuberculosisInnovationUniversitiesServicesBaseAreaCareerEpidemicLeadershipHiv InfectionsPreventionWorking GroupProductivityMedical SchoolsMentorsUnited States National Institutes Of Health
Grant awards (152)
The Johns Hopkins Center for AIDS Research (JHU CFAR)$2,753,957
P30 · FY2025 · AI · contact PI
JHU TRAC: Training and Supporting the Next Generation of TB Researchers$980,674
P30 · FY2025 · AI
Administrative Core$596,603
P30 · FY2025 · AI · contact PI
The Johns Hopkins Center for AIDS Research (JHU CFAR)$3,084,697
P30 · FY2024 · AI · contact PI
The Johns Hopkins Center for AIDS Research (JHU CFAR) AFRICURE$1,499,156
P30 · FY2024 · AI · contact PI
JHU TRAC: Training and Supporting the Next Generation of TB Researchers$980,674
P30 · FY2024 · AI
Safety and Tolerability of Ultra-short Course Rifapentine and Isoniazid (1HP) for Prevention of Tuberculosis in HIV-Uninfected Individuals$637,323
U01 · FY2024 · AI · contact PI
The CFAR Diversity, Equity, and Inclusion Pathway Initiative to Support The Continued Development of Generation Tomorrow (JHU CFAR Supplement)$610,084
P30 · FY2024 · AI · contact PI
Administrative Core$531,338
P30 · FY2024 · AI · contact PI
The Johns Hopkins Center for AIDS Research (JHU CFAR)$373,412
P30 · FY2024 · AI · contact PI
Ethics of Including Pregnant People in Clinical Trials$163,750
P30 · FY2024 · AI
The Johns Hopkins Center for AIDS Research (JHU CFAR)$133,267
P30 · FY2024 · AI · contact PI
The Johns Hopkins Center for AIDS Research (JHU CFAR)$130,018
P30 · FY2024 · AI · contact PI
The Johns Hopkins Center for AIDS Research (JHU CFAR)$5,400,009
P30 · FY2023 · AI · contact PI
JHU TRAC: Training and Supporting the Next Generation of TB Researchers$980,674
P30 · FY2023 · AI
Safety and Tolerability of Ultra-short Course Rifapentine and Isoniazid (1HP) for Prevention of Tuberculosis in HIV-Uninfected Individuals$961,935
U01 · FY2023 · AI · contact PI
Administrative Core$838,385
P30 · FY2023 · AI · contact PI
Core-008$448,538
P30 · FY2023 · AI · contact PI
Core-007$404,954
P30 · FY2023 · AI · contact PI
The Johns Hopkins Center for AIDS Research (JHU CFAR)$364,127
P30 · FY2023 · AI · contact PI
Administrative Core$364,127
P30 · FY2023 · AI · contact PI
The Johns Hopkins Center for AIDS Research (JHU CFAR)$161,319
P30 · FY2023 · AI · contact PI
Administrative Core$161,319
P30 · FY2023 · AI · contact PI
Administrative Core$134,497
P30 · FY2023 · AI · contact PI
The Johns Hopkins Center for AIDS Research (JHU CFAR)$134,497
P30 · FY2023 · AI · contact PI
The Johns Hopkins Center for AIDS Research (JHU CFAR)$4,698,359
P30 · FY2022 · AI · contact PI
The Johns Hopkins Center for AIDS Research (JHU CFAR)$1,253,590
P30 · FY2022 · AI · contact PI
JHU TRAC: Training and Supporting the Next Generation of TB Researchers$996,611
P30 · FY2022 · AI
Safety and Tolerability of Ultra-short Course Rifapentine and Isoniazid (1HP) for Prevention of Tuberculosis in HIV-Uninfected Individuals$957,056
U01 · FY2022 · AI · contact PI
Administrative Core$947,154
P30 · FY2022 · AI · contact PI
The Johns Hopkins Center for AIDS Research (JHU CFAR)$4,173,626
P30 · FY2021 · AI · contact PI
Safety and Tolerability of Ultra-short Course Rifapentine and Isoniazid (1HP) for Prevention of Tuberculosis in HIV-Uninfected Individuals$936,265
U01 · FY2021 · AI · contact PI
Administrative Core$764,910
P30 · FY2021 · AI · contact PI
The Johns Hopkins Center for AIDS Research (JHU CFAR)$4,645,338
P30 · FY2020 · AI · contact PI
The Johns Hopkins Center for AIDS Research (JHU CFAR) RADx-UP$3,222,658
P30 · FY2020 · AI · contact PI
Safety and Tolerability of Ultra-short Course Rifapentine and Isoniazid (1HP) for Prevention of Tuberculosis in HIV-Uninfected Individuals$916,330
U01 · FY2020 · AI · contact PI
Administrative Core$803,718
P30 · FY2020 · AI · contact PI
The Johns Hopkins Center for AIDS Research (JHU CFAR)$3,696,110
P30 · FY2019 · AI · contact PI
Administrative Core$959,749
P30 · FY2019 · AI · contact PI
The Johns Hopkins Center for AIDS Research (JHU CFAR)$3,868,228
P30 · FY2018 · AI · contact PI
Administrative Core$915,324
P30 · FY2018 · AI · contact PI
The Johns Hopkins Center for AIDS Research (JHU CFAR)$3,484,660
P30 · FY2017 · AI · contact PI
Administrative Core$967,702
P30 · FY2017 · AI · contact PI
The Johns Hopkins Center for AIDS Research (JHU CFAR)$2,999,995
P30 · FY2016 · AI · contact PI
Administrative Core$916,372
P30 · FY2016 · AI · contact PI
Developmental$734,249
P30 · FY2016 · AI · contact PI
Clinical$570,805
P30 · FY2016 · AI · contact PI
Clinical Laboratory and Biomarkers$344,302
P30 · FY2016 · AI · contact PI
Prevention$288,156
P30 · FY2016 · AI · contact PI
Biostatistics and Epidemiology Methodology$146,111
P30 · FY2016 · AI · contact PI
The Johns Hopkins Center for AIDS Research (JHU CFAR)$3,161,920
P30 · FY2015 · AI · contact PI
Developmental$1,060,443
P30 · FY2015 · AI · contact PI
Administrative Core$955,725
P30 · FY2015 · AI · contact PI
Impact of a New Molecular TB Test on TB/HIV Outcomes among HIV-Infected Malawians$578,551
R01 · FY2015 · AI · contact PI
Clinical$342,570
P30 · FY2015 · AI · contact PI
Prevention$303,952
P30 · FY2015 · AI · contact PI
Clinical Laboratory and Biomarkers$277,036
P30 · FY2015 · AI · contact PI
Biostatistics and Epidemiology Methodology$222,194
P30 · FY2015 · AI · contact PI
The Johns Hopkins Center for AIDS Research (JHU CFAR)$3,869,074
P30 · FY2014 · AI · contact PI
Developmental$1,782,775
P30 · FY2014 · AI · contact PI
Administrative Core$885,430
P30 · FY2014 · AI · contact PI
Impact of a New Molecular TB Test on TB/HIV Outcomes among HIV-Infected Malawians$558,148
R01 · FY2014 · AI · contact PI
The Johns Hopkins Center for AIDS Research (JHU CFAR)$479,976
P30 · FY2014 · AI · contact PI
Developmental$479,976
P30 · FY2014 · AI · contact PI
Impact of TB on Outcome of HIV in Pregnant Women$469,962
R01 · FY2014 · HD · contact PI
Impact of TB on Outcome of HIV in Pregnant Women$462,016
R01 · FY2014 · HD · contact PI
Clinical$460,346
P30 · FY2014 · AI · contact PI
Clinical Laboratory and Biomarkers$272,625
P30 · FY2014 · AI · contact PI
Prevention$253,562
P30 · FY2014 · AI · contact PI
Biostatistics and Epidemiology Methodology$214,336
P30 · FY2014 · AI · contact PI
The Johns Hopkins Center for AIDS Research (JHU CFAR)$3,826,810
P30 · FY2013 · AI · contact PI
Developmental$1,563,401
P30 · FY2013 · AI · contact PI
Administrative Core$944,290
P30 · FY2013 · AI · contact PI
Impact of a New Molecular TB Test on TB/HIV Outcomes among HIV-Infected Malawians$534,611
R01 · FY2013 · AI · contact PI
Prevention$459,801
P30 · FY2013 · AI · contact PI
Impact of TB on Outcome of HIV in Pregnant Women$451,892
R01 · FY2013 · HD · contact PI
Clinical$348,457
P30 · FY2013 · AI · contact PI
Biostatistics and Epidemiology Methodology$256,064
P30 · FY2013 · AI · contact PI
Clinical Laboratory and Biomarkers$254,797
P30 · FY2013 · AI · contact PI
The Johns Hopkins Center for AIDS Research (JHU CFAR)$2,999,995
P30 · FY2012 · AI · contact PI
Administrative Core$788,137
P30 · FY2012 · AI · contact PI
Impact of a New Molecular TB Test on TB/HIV Outcomes among HIV-Infected Malawians$565,070
R01 · FY2012 · AI · contact PI
Impact of TB on Outcome of HIV in Pregnant Women$478,129
R01 · FY2012 · HD · contact PI
Longitudinal Study of HIV-Associated Lung Infections in Soweto$285,062
R01 · FY2012 · HL · contact PI
Impact of TB on Outcome of HIV in Pregnant Women$156,368
R01 · FY2012 · HD · contact PI
Impact of a New Molecular TB Test on TB/HIV Outcomes among HIV-Infected Malawians$605,961
R01 · FY2011 · AI · contact PI
Longitudinal Study of HIV-Associated Lung Infections in Soweto$592,303
R01 · FY2011 · HL · contact PI
Impact of TB on Outcome of HIV in Pregnant Women$484,884
R01 · FY2011 · HD · contact PI
Innovative Approaches for TB Control in Brazil$226,429
U2R · FY2011 · TW · contact PI
Longitudinal Study of HIV-Associated Lung Infections in Soweto$594,747
R01 · FY2010 · HL · contact PI
Impact of TB on Outcome of HIV in Pregnant Women$509,029
R01 · FY2010 · HD · contact PI
Innovative Approaches for TB Control in Brazil$231,432
U2R · FY2010 · TW · contact PI
Innovative Approaches to Tuberculosis Control$876,125
U19 · FY2009 · AI · contact PI
Longitudinal Study of HIV-Associated Lung Infections in Soweto$598,562
R01 · FY2009 · HL · contact PI
Innovative Approaches for Tuberculosis Control in Brazil$178,600
U2R · FY2009 · TW · contact PI
Clinical Research in Tuberculosis$155,375
K24 · FY2009 · AI · contact PI
Innovative Approaches to Tuberculosis Control$893,064
U19 · FY2008 · AI · contact PI
Longitudinal Study of HIV-Associated Lung Infections in Soweto$601,409
R01 · FY2008 · HL · contact PI
Novel TB Prevention Regimens for HIV-Infected Adults$573,817
R01 · FY2008 · AI · contact PI
DOT-HAART for HIV-Infected South African Adults$514,599
R01 · FY2008 · AI · contact PI
Innovative Approaches for Tuberculosis Control in Brazil$200,925
U2R · FY2008 · TW · contact PI
Clinical Research in Tuberculosis$155,375
K24 · FY2008 · AI · contact PI
Innovative Approaches to Tuberculosis Control$806,190
U19 · FY2007 · AI · contact PI
Longitudinal Study of HIV-Associated Lung Infections in Soweto$617,155
R01 · FY2007 · HL · contact PI
Novel TB Prevention Regimens for HIV-Infected Adults$544,836
R01 · FY2007 · AI · contact PI
DOT-HAART for HIV-Infected South African Adults$518,269
R01 · FY2007 · AI · contact PI
DOT-HAART for HIV-Infected South African Adults$250,000
R01 · FY2007 · AI · contact PI
Innovative Approaches for Tuberculosis Control in Brazil$235,000
U2R · FY2007 · TW · contact PI
Clinical Research in Tuberculosis$155,375
K24 · FY2007 · AI · contact PI
Novel TB Prevention Regimens for HIV-Infected Adults$150,000
R01 · FY2007 · AI · contact PI
PHASE II TRIAL OF MOXIFLOXACIN FOR TB$64,221
R01 · FY2007 · FD · contact PI
Innovative Approaches to Tuberculosis Control$831,789
U19 · FY2006 · AI · contact PI
Novel TB Prevention Regimens for HIV-Infected Adults$568,534
R01 · FY2006 · AI · contact PI
PHASE II TRIAL OF MOXIFLOXACIN FOR TB$453,224
R01 · FY2006 · FD · contact PI
Innovative Approaches for TB Control in Brazil$261,250
U2R · FY2006 · TW · contact PI
Clinical Research in Tuberculosis$155,375
K24 · FY2006 · AI · contact PI
Novel TB Prevention Regimens for HIV-Infected Adults$120,275
R01 · FY2006 · AI · contact PI
Novel TB Prevention Regimens for HIV-Infected Adults$801,305
R01 · FY2005 · AI
Innovative Approaches to Tuberculosis Control$664,048
U19 · FY2005 · AI
DOT-HAART for HIV-Infected South African Adults$533,524
R01 · FY2005 · AI
Innovative Approaches for TB Control in Brazil$300,000
U2R · FY2005 · TW
Administrative Core$158,008
U19 · FY2005 · AI
Clinical Research in Tuberculosis$151,994
K24 · FY2005 · AI
Novel TB Prevention Regimens for HIV-Infected Adults$768,345
R01 · FY2004 · AI
INNOVATIVE APPROACHES TO TUBERCULOSIS CONTROL$642,176
U19 · FY2004 · AI
DOT-HAART for HIV-Infected South African Adults$528,025
R01 · FY2004 · AI
ABC TRAINING GRANT FOR RIO DE JANEIRO ICIDR$100,000
D43 · FY2004 · TW
Novel TB Prevention Regimens for HIV-Infected Adults$715,123
R01 · FY2003 · AI
INNOVATIVE APPROACHES TO TUBERCULOSIS CONTROL$651,816
U19 · FY2003 · AI
DOT-HAART for HIV-Infected South African Adults$271,689
R01 · FY2003 · AI
CLINICAL RESEARCH IN TUBERCULOSIS$143,124
K24 · FY2003 · AI
ABC TRAINING GRANT FOR RIO DE JANEIRO ICIDR$100,000
D43 · FY2003 · TW
ABC TRAINING GRANT FOR RIO DE JANEIRO ICIDR$51,378
D43 · FY2003 · TW
Novel TB Prevention Regimens for HIV-Infected Adults$663,268
R01 · FY2002 · AI
INNOVATIVE APPROACHES TO TUBERCULOSIS CONTROL$593,123
U19 · FY2002 · AI
CLINICAL RESEARCH IN TUBERCULOSIS$143,124
K24 · FY2002 · AI
ABC TRAINING GRANT FOR RIO DE JANEIRO ICIDR$100,000
D43 · FY2002 · TW
TRIAL OF RIFAPENTINE AND ISONIAZID THERAPY FOR TB$0
M01 · FY2002 · RR
IMPROVING MEDICATION ADHERENCE AMONG HIV INFECTED PATIENTS$0
M01 · FY2002 · RR
INNOVATIVE APPROACHES TO TUBERCULOSIS CONTROL$673,072
U19 · FY2001 · AI
Novel TB Prevention Regimens for HIV-Infected Adults$625,123
R01 · FY2001 · AI
CLINICAL RESEARCH IN TUBERCULOSIS$116,526
K24 · FY2001 · AI
CLINICAL TRAINING IN HIV$101,433
T32 · FY2001 · AI
ABC TRAINING GRANT FOR RIO DE JANEIRO ICIDR$100,000
D43 · FY2001 · TW
TRIAL OF RIFAPENTINE AND ISONIAZID THERAPY FOR TB$0
M01 · FY2001 · RR
IMPROVING MEDICATION ADHERENCE AMONG HIV INFECTED PATIENTS$0
M01 · FY2001 · RR
INNOVATIVE APPROACHES TO TUBERCULOSIS CONTROL$630,338
U19 · FY2000 · AI
CLINICAL RESEARCH IN TUBERCULOSIS$113,918
K24 · FY2000 · AI
ABC TRAINING GRANT FOR RIO DE JANEIRO ICIDR$100,000
D43 · FY2000 · TW
CLINICAL TRAINING IN HIV$98,800
T32 · FY2000 · AI
IMPROVING MEDICATION ADHERENCE AMONG HIV INFECTED PATIENTS$0
M01 · FY2000 · RR
TRIAL OF RIFAPENTINE AND ISONIAZID THERAPY FOR TB$0
M01 · FY2000 · RR